| Nicholas Florence, MD | |
|
1300 Franklin Ave, Normal, IL 61761-3592 | |
| (309) 454-1400 | |
| Not Available |
| Full Name | Nicholas Florence |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 9 Years |
| Location | 1300 Franklin Ave, Normal, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093100554 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Bromenn Medical Center | Normal, IL | Hospital |
| Advocate Eureka Hospital | Eureka, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carle West Physician Group Inc | 8921420308 | 254 |
News Archive
The Obama "administration's bold drive to improve the U.S.'s notoriously bureaucratic and dysfunctional foreign aid programme is setting out with highly uncertain chances of success," the Financial Times writes. "Officials acknowledge inadequacies in the traditional U.S. approach. The U.S. programme involves overlapping bureaucracies ... [and] frequently 'ties' U.S. aid to the purchase of American food and other goods and consultancy services," according to the article.
Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.
As the threat of AMR grows, hand hygiene compliance will become critical, but it is often difficult for healthcare environments to maintain. One of the best ways to improve compliance rates is to make the procedures quick and easy to follow – without undermining their efficacy.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
› Verified 9 days ago
| Entity Name | Graham Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780692087 PECOS PAC ID: 2769375021 Enrollment ID: O20040510000873 |
News Archive
The Obama "administration's bold drive to improve the U.S.'s notoriously bureaucratic and dysfunctional foreign aid programme is setting out with highly uncertain chances of success," the Financial Times writes. "Officials acknowledge inadequacies in the traditional U.S. approach. The U.S. programme involves overlapping bureaucracies ... [and] frequently 'ties' U.S. aid to the purchase of American food and other goods and consultancy services," according to the article.
Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.
As the threat of AMR grows, hand hygiene compliance will become critical, but it is often difficult for healthcare environments to maintain. One of the best ways to improve compliance rates is to make the procedures quick and easy to follow – without undermining their efficacy.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
› Verified 9 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
The Obama "administration's bold drive to improve the U.S.'s notoriously bureaucratic and dysfunctional foreign aid programme is setting out with highly uncertain chances of success," the Financial Times writes. "Officials acknowledge inadequacies in the traditional U.S. approach. The U.S. programme involves overlapping bureaucracies ... [and] frequently 'ties' U.S. aid to the purchase of American food and other goods and consultancy services," according to the article.
Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.
As the threat of AMR grows, hand hygiene compliance will become critical, but it is often difficult for healthcare environments to maintain. One of the best ways to improve compliance rates is to make the procedures quick and easy to follow – without undermining their efficacy.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
› Verified 9 days ago
| Entity Name | Bloomington Radiology S C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700831773 PECOS PAC ID: 5092797621 Enrollment ID: O20040607000336 |
News Archive
The Obama "administration's bold drive to improve the U.S.'s notoriously bureaucratic and dysfunctional foreign aid programme is setting out with highly uncertain chances of success," the Financial Times writes. "Officials acknowledge inadequacies in the traditional U.S. approach. The U.S. programme involves overlapping bureaucracies ... [and] frequently 'ties' U.S. aid to the purchase of American food and other goods and consultancy services," according to the article.
Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.
As the threat of AMR grows, hand hygiene compliance will become critical, but it is often difficult for healthcare environments to maintain. One of the best ways to improve compliance rates is to make the procedures quick and easy to follow – without undermining their efficacy.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
› Verified 9 days ago
| Entity Name | Richland Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467492124 PECOS PAC ID: 3870565732 Enrollment ID: O20040811000131 |
News Archive
The Obama "administration's bold drive to improve the U.S.'s notoriously bureaucratic and dysfunctional foreign aid programme is setting out with highly uncertain chances of success," the Financial Times writes. "Officials acknowledge inadequacies in the traditional U.S. approach. The U.S. programme involves overlapping bureaucracies ... [and] frequently 'ties' U.S. aid to the purchase of American food and other goods and consultancy services," according to the article.
Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.
As the threat of AMR grows, hand hygiene compliance will become critical, but it is often difficult for healthcare environments to maintain. One of the best ways to improve compliance rates is to make the procedures quick and easy to follow – without undermining their efficacy.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
› Verified 9 days ago
| Entity Name | Ft Jesse Imaging Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245287143 PECOS PAC ID: 1951379106 Enrollment ID: O20070117000072 |
News Archive
The Obama "administration's bold drive to improve the U.S.'s notoriously bureaucratic and dysfunctional foreign aid programme is setting out with highly uncertain chances of success," the Financial Times writes. "Officials acknowledge inadequacies in the traditional U.S. approach. The U.S. programme involves overlapping bureaucracies ... [and] frequently 'ties' U.S. aid to the purchase of American food and other goods and consultancy services," according to the article.
Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.
As the threat of AMR grows, hand hygiene compliance will become critical, but it is often difficult for healthcare environments to maintain. One of the best ways to improve compliance rates is to make the procedures quick and easy to follow – without undermining their efficacy.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
› Verified 9 days ago
| Entity Name | Carle Health Care Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154653947 PECOS PAC ID: 3577515774 Enrollment ID: O20100513000829 |
News Archive
The Obama "administration's bold drive to improve the U.S.'s notoriously bureaucratic and dysfunctional foreign aid programme is setting out with highly uncertain chances of success," the Financial Times writes. "Officials acknowledge inadequacies in the traditional U.S. approach. The U.S. programme involves overlapping bureaucracies ... [and] frequently 'ties' U.S. aid to the purchase of American food and other goods and consultancy services," according to the article.
Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.
As the threat of AMR grows, hand hygiene compliance will become critical, but it is often difficult for healthcare environments to maintain. One of the best ways to improve compliance rates is to make the procedures quick and easy to follow – without undermining their efficacy.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
› Verified 9 days ago
| Entity Name | Carle West Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467074138 PECOS PAC ID: 8921420308 Enrollment ID: O20200613000147 |
News Archive
The Obama "administration's bold drive to improve the U.S.'s notoriously bureaucratic and dysfunctional foreign aid programme is setting out with highly uncertain chances of success," the Financial Times writes. "Officials acknowledge inadequacies in the traditional U.S. approach. The U.S. programme involves overlapping bureaucracies ... [and] frequently 'ties' U.S. aid to the purchase of American food and other goods and consultancy services," according to the article.
Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.
As the threat of AMR grows, hand hygiene compliance will become critical, but it is often difficult for healthcare environments to maintain. One of the best ways to improve compliance rates is to make the procedures quick and easy to follow – without undermining their efficacy.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Florence, MD 611 W Park St, Fapc, Urbana, IL 61801-2500 Ph: () - | Nicholas Florence, MD 1300 Franklin Ave, Normal, IL 61761-3592 Ph: (309) 454-1400 |
News Archive
The Obama "administration's bold drive to improve the U.S.'s notoriously bureaucratic and dysfunctional foreign aid programme is setting out with highly uncertain chances of success," the Financial Times writes. "Officials acknowledge inadequacies in the traditional U.S. approach. The U.S. programme involves overlapping bureaucracies ... [and] frequently 'ties' U.S. aid to the purchase of American food and other goods and consultancy services," according to the article.
Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.
As the threat of AMR grows, hand hygiene compliance will become critical, but it is often difficult for healthcare environments to maintain. One of the best ways to improve compliance rates is to make the procedures quick and easy to follow – without undermining their efficacy.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
› Verified 9 days ago
Dr. Daniel L Ha, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2200 Fort Jesse Rd, Suite 280, Normal, IL 61761 Phone: 309-452-1788 Fax: 309-862-1302 | |
Dr. Ajay R Malpani, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2200 Fort Jesse Rd, Suite 280, Normal, IL 61761 Phone: 309-452-1788 Fax: 309-862-1302 | |
Patrick S Fernandes, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 407 E Vernon Ave, Normal, IL 61761 Phone: 309-451-2231 Fax: 309-451-2299 | |
Dr. Carlos P Capati, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2200 Fort Jesse Rd, Suite 280, Normal, IL 61761 Phone: 309-452-1788 Fax: 309-862-1302 | |
Dr. David Koch, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2200 Fort Jesse Rd, Suite 280, Normal, IL 61761 Phone: 309-452-1788 Fax: 309-862-1302 | |
Amit Vyas, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2200 Fort Jesse Road, Ste. 280, Normal, IL 61761 Phone: 730-945-2178 Fax: 309-862-1302 | |
Dr. Chung H Lee, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2200 Fort Jesse Rd, Suite 280, Normal, IL 61761 Phone: 309-452-1788 Fax: 309-862-1302 |